Your browser doesn't support javascript.
loading
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Gutjahr, Julia C; Bayer, Elisabeth; Yu, Xiaobing; Laufer, Julia M; Höpner, Jan P; Tesanovic, Suzana; Härzschel, Andrea; Auer, Georg; Rieß, Tanja; Salmhofer, Astrid; Szenes, Eva; Haslauer, Theresa; Durand-Onayli, Valerie; Ramspacher, Andrea; Pennisi, Sandra P; Artinger, Marc; Zaborsky, Nadja; Chigaev, Alexandre; Aberger, Fritz; Neureiter, Daniel; Pleyer, Lisa; Legler, Daniel F; Orian-Rousseau, Veronique; Greil, Richard; Hartmann, Tanja N.
Affiliation
  • Gutjahr JC; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Bayer E; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Yu X; Karlsruhe Institute of Technology, Institute of Toxicology and Genetics.
  • Laufer JM; Biotechnology Institute Thurgau (BITg) at the University of Konstanz.
  • Höpner JP; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Tesanovic S; Department Biosciences, Paris-Lodron University of Salzburg.
  • Härzschel A; Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg.
  • Auer G; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Rieß T; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Salmhofer A; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Szenes E; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Haslauer T; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Durand-Onayli V; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Ramspacher A; Department Biosciences, Paris-Lodron University of Salzburg.
  • Pennisi SP; Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg.
  • Artinger M; Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland.
  • Zaborsky N; 1Laboratory for Immunological and Molecular Cancer Research.
  • Chigaev A; Department of Pathology and Cancer Center, University of New Mexico.
  • Aberger F; Department Biosciences, Paris-Lodron University of Salzburg.
  • Neureiter D; Institute of Pathology, Paracelsus Medical University Salzburg.
  • Pleyer L; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Legler DF; Biotechnology Institute Thurgau (BITg) at the University of Konstanz.
  • Orian-Rousseau V; Karlsruhe Institute of Technology, Institute of Toxicology and Genetics.
  • Greil R; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Hartmann TN; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
Haematologica ; 106(8): 2102-2113, 2021 08 01.
Article in En | MEDLINE | ID: mdl-32616529
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Integrin alpha4beta1 Limits: Humans Language: En Journal: Haematologica Year: 2021 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Integrin alpha4beta1 Limits: Humans Language: En Journal: Haematologica Year: 2021 Type: Article